American Assets Inc
SPRY icon

American Assets Inc’s ARS Pharmaceuticals SPRY Stock Holding History

American Assets Inc’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$539K Hold
125,000
– – 0.17% 11
2026
Q2 		$1M Buy
125,000
+118,000
+1,686% +$1.02M 0.3% 8
2026
Q1 		$1.71M Sell
7,000
-48,000
-87% -$460K 0.57% 6
2025
Q4 		$641K Hold
55,000
– – 0.2% 18
2025
Q3 		$553K Buy
+55,000
New +$789K 0.18% 23

Other funds holding SPRY

Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Investment Management Associates
Investment Management Associates Greenwood Village, Colorado $490M AUM 6.7% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Norman Fields Gottscho Capital Management
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
Matisse Capital
Matisse Capital Portland, Oregon $256M AUM 15.28% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
USAdvisors Wealth Management
USAdvisors Wealth Management Eden Prairie, Minnesota $351M AUM 13.01% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

American Assets Inc's SPRY Position: Q3 2026 in Review

American Assets Inc held its ARS Pharmaceuticals (SPRY) position steady in Q3 2026 at 125,000 shares worth $539K. The position accounts for 0.17% of the portfolio, ranked #11.

American Assets Inc first reported a position in SPRY in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.71M in Q1 2026. 33 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.

  • American Assets Inc held 125,000 shares of ARS Pharmaceuticals worth $539K as of Q3 2026.
  • American Assets Inc left its ARS Pharmaceuticals share count unchanged in Q3 2026.
  • ARS Pharmaceuticals made up 0.17% of American Assets Inc's portfolio in Q3 2026, its #11 holding.
  • American Assets Inc first reported a position in ARS Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • American Assets Inc's ARS Pharmaceuticals position peaked at $1.71M in Q1 2026.
  • 33 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.

Based on American Assets Inc's 13F filing for Q3 2026, filed 30 Oct 2026.